Home
New Reports
- Strategic Medical Publications Management (PH163)
- Pharmaceutical Portfolio Management (PH162)
- Pharmaceutical Digital Marketing and Social Media (PH161)
- Health Outcomes Liaisons (PH159)
- Succession Planning (FL56)
- Investigator Initiated Trial Management (PH158)
- Market Access Management (PH160)
- Phase IV Clinical Trials (PH157)
- Business Development and Licensing (PH154)
- KOL Fair-Market Value and Aggregate Spend (PH155)
- Pharmaceutical Marketing Strategy (PH156)
- Pharmaceutical Pricing Strategy (PH153)
Cutting Edge Information
The pharmaceutical and biotech industries’
top source for business research, decision
support and benchmarking insights.
What’s New at CEI?
- Blog: Extended Sunshine Act Deadline Provides Extra Time to Track Physician Payments
- New Report: Leverage the Power of Your Medical Publications
- Featured Research: Build a Compliant Digital Marketing Strategy
- Casey Ferrell Discusses CEI's New Digital Marketing Report
- Subscribe to Our Free Industry Newsletters
“I’d like to take this opportunity to thank you and your staff for the successful project. It was beyond my expectations in that it was very comprehensive, well planned and answered all questions I posed. Your thoughtful approach and reach into the industry are very impressive. Sincere thanks for your effort – this was extremely helpful.” – Vice President of Clinical Operations, Top 5 Consumer Products Company
More Testimonials >
